全文获取类型
收费全文 | 36082篇 |
免费 | 3183篇 |
国内免费 | 1798篇 |
专业分类
耳鼻咽喉 | 582篇 |
儿科学 | 510篇 |
妇产科学 | 821篇 |
基础医学 | 4223篇 |
口腔科学 | 573篇 |
临床医学 | 4255篇 |
内科学 | 6308篇 |
皮肤病学 | 815篇 |
神经病学 | 1960篇 |
特种医学 | 1205篇 |
外国民族医学 | 17篇 |
外科学 | 3660篇 |
综合类 | 4326篇 |
现状与发展 | 4篇 |
一般理论 | 7篇 |
预防医学 | 2353篇 |
眼科学 | 806篇 |
药学 | 3666篇 |
31篇 | |
中国医学 | 1697篇 |
肿瘤学 | 3244篇 |
出版年
2024年 | 305篇 |
2023年 | 610篇 |
2022年 | 1181篇 |
2021年 | 1556篇 |
2020年 | 1188篇 |
2019年 | 1171篇 |
2018年 | 1292篇 |
2017年 | 1104篇 |
2016年 | 1050篇 |
2015年 | 1554篇 |
2014年 | 1903篇 |
2013年 | 1892篇 |
2012年 | 2668篇 |
2011年 | 2805篇 |
2010年 | 1792篇 |
2009年 | 1332篇 |
2008年 | 1928篇 |
2007年 | 1836篇 |
2006年 | 1861篇 |
2005年 | 1825篇 |
2004年 | 1330篇 |
2003年 | 1270篇 |
2002年 | 1092篇 |
2001年 | 900篇 |
2000年 | 824篇 |
1999年 | 749篇 |
1998年 | 458篇 |
1997年 | 413篇 |
1996年 | 335篇 |
1995年 | 306篇 |
1994年 | 275篇 |
1993年 | 197篇 |
1992年 | 327篇 |
1991年 | 285篇 |
1990年 | 219篇 |
1989年 | 171篇 |
1988年 | 193篇 |
1987年 | 158篇 |
1986年 | 124篇 |
1985年 | 119篇 |
1984年 | 84篇 |
1983年 | 45篇 |
1982年 | 25篇 |
1981年 | 35篇 |
1980年 | 22篇 |
1979年 | 32篇 |
1978年 | 24篇 |
1977年 | 19篇 |
1975年 | 18篇 |
1973年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound 总被引:3,自引:0,他引:3
Wu F Wang ZB Cao YD Chen WZ Zou JZ Bai J Zhu H Li KQ Jin CB Xie FL Su HB Gao GW 《Ultrasound in medicine & biology》2003,29(10):1487-1492
Proliferation, invasion, immortalization and metastasis are the main malignant characteristics of cancer. Previous studies have shown that high-intensity focused ultrasound (US), or HIFU, can induce irreversible damage both to breast cancer cells and to tumor blood vessels. However, light microscopy alone may not always show this clearly. In this study, molecular biologic techniques were used to examine any changes in molecular markers associated with malignant behavior after exposure to HIFU. A total of 48 women with breast cancer were randomized to a control group (mastectomy) and a HIFU group (HIFU followed by mastectomy). Immunohistochemical staining, messenger RNA (mRNA) in situ hybridization and telomere-repeat amplification protocol-enzyme-linked immunosorbent assay (TRAP-ELISA) techniques were used to detect tumor expression of proliferating cell nuclear antigen (PCNA), cell adhesion molecule CD44v6, matrix metalloproteinase-9 (MMP-9), erbB2 mRNA, and to measure telomerase activity in both groups. The results demonstrated that there were significant alterations in expression of PCNA, CD44v6, MMP-9, erbB2 mRNA, and a dramatic decrease in telomerase activity in the HIFU group. It is concluded that malignant tumor characteristics are arrested by HIFU, and that biologic factors are potential markers for assessing HIFU efficacy. 相似文献
64.
目的:观察肺癌患者中西医结合治疗后其舌脉象参数变化情况,探讨舌脉象参数变化在肺癌患者中西医结合治疗过程中的临床意义。方法:于2015年1月至2016年4月,选取该阶段内我院采取中西医结合疗法治疗的50例肺癌患者作为此次研究的对象,分别于治疗前、治疗后1个月、治疗后2个月,采用舌脉象数字化分析仪对肺癌患者的舌象图片和关部脉图进行检测,比较治疗前、治疗后1个月、治疗后2个月患者的舌象参数、脉象参数。结果:与治疗前相比,治疗后1个月、治疗后2个月肺癌患者脉象参数中的PSR1明显增高(P0.05),PSR2明显降低(P0.05);与治疗后1个月相比,治疗后2个月肺癌患者脉象参数中的PSR1明显降低(P0.05),PSR2、PSR3均明显增高(P0.05);治疗前与治疗后相比,肺癌患者的脉象参数CSR1、CSR2、CSR3均未出现明显改变(P0.05)。与治疗前相比,治疗后1个月肺癌患者的舌象润燥指数、腐腻指数、裂纹指数均明显增高(P0.05),厚薄指数明显降低(P0.05);与治疗后1个月相比,治疗后2个月肺癌患者的裂纹指数明显降低(P0.05),厚薄指数明显增高(P0.05),润燥指数和腐腻指数未发生明显改变(P0.05)。结论:在肺癌患者采用中西医结合疗法治疗的过程中,舌脉象参数的变化可有效反映肺癌患者的中西医结合治疗效果,可作为中西医结合治疗肺癌的疗效评估指标。 相似文献
65.
Effects of Rubiadin isolated from Prismatomeris connata on anti‐hepatitis B virus activity in vitro 下载免费PDF全文
Zheng Peng Gang Fang Fenghui Peng Zhiyu Pan Zhengying Su Wei Tian Huaxin Hou 《Phytotherapy research : PTR》2017,31(12):1962-1970
Prismatomeris connata was a kind of Rubiaceae plant for treatment of hepatitis, hepatic fibrosis and silicosis. Whereas, the effective components of Prismatomeris connata remains unexplored. The aim of this study was to investigate the inhibitory effects and mechanisms of Rubiadin isolated from Prismatomeris connata against HBV using HepG2.2.15 cells. The levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme‐linked immunosorbent assay. HBV DNA was qualified q‐PCR. Rubiadin was isolated by silica gel column. The structure of the compound was elucidated by HPLC, FT‐IR, 1H‐NMR, 13C‐NMR and identified as 1,3‐Dihydroxy‐2‐methyl‐9, 10‐anthraquinone. Rubiadin significantly decreased HBeAg,HBcAg secretion level and inhibit HBV DNA replication. Rubiadin inhibits the proliferation of the cells and HBx protein expression in a dose‐dependent manner. The intracellular calcium concentration was significantly reduced. These results demonstrated that Rubiadin could inhibit HepG2.2.15 cells proliferation, reduce the level of HBx expression, and intracellular free calcium, which might become a novel anti‐HBV drug candidate. 相似文献
66.
67.
Ji Su Jang Yeon‐Hee Lee Hemant K. Kandahar Suman K. Shrestha Jae Sung Lee Jin‐Koo Lee Seung Jae Park Na Rea Lee Jae Jun Lee Sang‐Soo Lee 《Brazilian Journal of Anesthesiology》2018,68(6):558-563
Background and objectives
An ultrasound guided femoral nerve block is an established analgesic method in patients with a hip fracture. Elevated cytokine levels correlate with poor patient outcomes after surgery. Hence, the aim of the study was to describe the levels of tumor necrosis factor‐α after an ultrasound‐guided femoral nerve block in elderly patients having a femoral neck fracture.Methods
A total of 32 patients were allocated into two treatment groups: 16 patients (femoral nerve block group; ultrasound‐guided femoral nerve block with up to 20 mL of 0.3 mL.kg?1 of 0.5% bupivacaine and intravenous tramadol) and 16 patients (standard management group; up to 3 mL of 0.9% saline in the femoral sheath and intravenous tramadol). Tumor necrosis factor‐α and visual analogue scale scores were evaluated immediately before the femoral nerve block and again at 4, 24, and 48 h after the femoral nerve block. All surgery was performed electively after 48 h of femoral nerve block.Results
The femoral nerve block group had a significantly lower mean tumor necrosis factor‐α level at 24 (4.60 vs. 8.14, p < 0.001) and 48 h (5.05 vs. 8.56, p < 0.001) after the femoral nerve block, compared to the standard management group. The femoral nerve block group showed a significantly lower mean visual analogue scale score at 4 (3.63 vs. 7.06, p < 0.001) and 24 h (4.50 vs. 5.75, p < 0.001) after the femoral nerve block, compared to the standard management group.Conclusions
Ultrasound‐guided femoral nerve block using 0.3 mL.kg?1 of 0.5% bupivacaine up to a maximum of 20 mL resulted in a significant lower tumor necrosis factor‐α level. 相似文献68.
J.-F. Cai W. Wang W. Hao Z.-J. Sun L.-L. Su X. Li X. Zheng X.-D. Zhang 《Transplantation proceedings》2018,50(10):3411-3415
Background
Ureteral stents have been widely used in kidney transplantation to prevent postoperative ureter-related complications such as ureteral stricture, ureteral obstruction, and ureteral leakage; however, a longer indwelling ureteral stent time corresponds to a greater risk of complications such as urinary tract infections. Currently, transplantation centers have not yet reached an agreement on the time to remove ureteral stents. Several randomized controlled trials (RCTs) have evaluated the optimal removal time for ureteral stents.Objective
This meta-analysis was designed to evaluate and discuss the optimal removal time for ureteral stents after kidney transplantation.Method
We used key words to search PubMed, Embase, and Cochrane Library and retrieve published articles. A total of 568 kidney transplantation patients from 5 RCTs were included in this meta-analysis. We collected information regarding postoperative complications related to indwelling stents, such as ureteral stricture, ureteral obstruction, ureteral leakage, and urinary tract infection, and evaluated whether early removal of ureteral stents (≤7 days) was superior to late removal (≥14 days).Results
A significant difference was observed in the incidence of urinary tract infection between the early removal group and the late removal group (risk ratio [RR] = 0.43, 95% confidence interval [CI] [0.32, 0.59], P < .01). No significant between-group difference was observed in the incidence of major urological complications (MUCs) (RR = 1.87, 95% CI [0.45, 7.70], P > .05).Conclusion
Early removal of ureteral stents of transplanted kidneys after kidney transplantation (≤7 days) did not significantly increase the incidence of postoperative MUCs (ureteral stricture, ureteral obstruction, and ureteral leakage) relative to late removal (≥14 days). Early removal may significantly reduce the incidence of postoperative urinary tract infection relative to late removal. 相似文献69.
S. González Martínez A. Molina Raya A. Becerra Massare K. Muffak Granero T. Villegas Herrera J.M. Villar del Moral Y. Fundora Suárez 《Transplantation proceedings》2018,50(2):595-597
Objectives
The score in the Model of End-stage Liver Disease, or MELD, is a good indicator of the survival in patients on the liver transplant waiting list. In this study, an analysis is performed on the benefits of liver transplant on those patients with a very high MELD score and who thus start from a very severe baseline state that could affect the surgical outcome.Materials and methods
A prospective study was conducted on a cohort of 331 patients that received a liver transplant between 2002 and 2014. The patients were divided into 2 groups according to the MELD score (<28 vs ≥28), and differences in age, postoperative complications, stay in the intensive care unit (ICU), hospital stay, and survival were compared.Results
Of the total of 331 patients, 21 (6.3%) had a MELD score ≥ 28. The mean age of the group with MELD score ≥ 28 was lower than the age in the group with MEDL score < 28 (42.5 vs 53.7 years; P < .0001). No significant increase was observed in postoperative complications. Although there were also no differences in survival, the group with MELD score ≥ 28 did have a longer stay in ICU and a longer hospital stay (with a mean of 6.7 days in ICU and 41.5 days admission vs 4.1 and 26.9, respectively).Conclusions
A very high MELD score is associated with a longer stay in ICU and more days of hospital admission, although no differences were observed in postoperative complications or survival. Therefore, there does not seem to be any contraindication in transplantation in this group of patients. 相似文献70.
M. Cintra-Cabrera A. Suárez-Benjumea G. Bernal-Blanco F.M. González-Roncero N.G. Toapanta-Gaibor M. Súñer-Poblet M.Á. Pérez-Valdivia F. Fernández-Cuenca M.Á. Gentil-Govantes J.L. Rocha-Castilla 《Transplantation proceedings》2018,50(2):575-577